Analysis: Medeva ruling disappoints in the details
Medeva and Georgetown could suffer from this morning’s ruling from the Court of Justice of the EU (CJ), despite being likely to win their cases
The questions referred from the Court of Appeal in London in two cases – Medeva and Georgetown – concerned the circumstances under which a patent or a product that has won market authorisation can be awarded a supplementary protection certificate...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.